Evidence map›Paper›PMID 41726391›Full record

ArticleHemaSphere2026

Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis.

Bella Banjanin, James Nagai, YeVin Mun, Stijn Fuchs, Inge Snoeren, Joachim Boers, Mayra L Ruiz Tejada Segura, Hector Tejeda Mora, Anna Katharina Galyga, Adam Benabid and 24 more

Abstract read
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Bella BanjaninDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.
James NagaiInstitute for Computational Genomics, Faculty of Medicine RWTH Aachen University Aachen Germany.
YeVin MunDepartment of Medical Oncology and Hematology University Hospital Zurich Zürich Switzerland.
Stijn FuchsDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.
Inge SnoerenDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.
Joachim BoersDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.
Mayra L Ruiz Tejada SeguraInstitute for Computational Genomics, Faculty of Medicine RWTH Aachen University Aachen Germany.
Hector Tejeda MoraDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.
Anna Katharina GalygaOncode Institute, Erasmus Medical Center Rotterdam The Netherlands.
Adam BenabidOncode Institute, Erasmus Medical Center Rotterdam The Netherlands.
Rita SarkisLaboratory of Regenerative Hematopoiesis University of Lausanne Lausanne Switzerland.
Olaia NaveirasLaboratory of Regenerative Hematopoiesis University of Lausanne Lausanne Switzerland.
Marta RizkDepartment of Orthodontics, Dental Clinic RWTH Aachen University Aachen Germany.
Michael WolfDepartment of Orthodontics, Dental Clinic RWTH Aachen University Aachen Germany.
Rogerio B CraveiroDepartment of Orthodontics, Dental Clinic RWTH Aachen University Aachen Germany.
Fabian PeiskerDepartment of Medicine II (Nephrology, Rheumatology, Immunology and Hypertension), Faculty of Medicine RWTH Aachen University Aachen Germany.
Ursula StalmannDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.
Jessica E PritchardOncode Institute, Erasmus Medical Center Rotterdam The Netherlands.
Hosuk RyouDepartment of Cellular Pathology, John Radcliffe Hospital, Oxford University NHS Foundation Trust, and Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine John Radcliffe Hospital Oxford United Kingdom.
Nasullah Khalid AlhamDepartment of Cellular Pathology, John Radcliffe Hospital, Oxford University NHS Foundation Trust, and Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine John Radcliffe Hospital Oxford United Kingdom.
Marek WeilerDepartment of Experimental Molecular Imaging, Faculty of Medicine RWTH Aachen University Aachen Germany.
Fabian KiesslingDepartment of Experimental Molecular Imaging, Faculty of Medicine RWTH Aachen University Aachen Germany.
Twan LammersDepartment of Experimental Molecular Imaging, Faculty of Medicine RWTH Aachen University Aachen Germany.
Anna Rita MigliaccioAltius Institute for Biomedical Sciences Seattle Washington United States.
Kishor Kumar SivarajDepartment of Tissue Morphogenesis Max Planck Institute for Molecular Biomedicine Münster Germany.
Ralf H AdamsDepartment of Tissue Morphogenesis Max Planck Institute for Molecular Biomedicine Münster Germany.
Eric BindelsDepartment of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.
Joost GribnauDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.
Daniel RoystonDepartment of Cellular Pathology, John Radcliffe Hospital, Oxford University NHS Foundation Trust, and Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine John Radcliffe Hospital Oxford United Kingdom.ORCID https://orcid.org/0000-0002-5151-2378
Hélène F E GleitzDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.ORCID https://orcid.org/0000-0001-6138-8916
Rafael KramannDepartment of Medicine II (Nephrology, Rheumatology, Immunology and Hypertension), Faculty of Medicine RWTH Aachen University Aachen Germany.ORCID https://orcid.org/0000-0003-4048-6351
César Nombela-ArrietaDepartment of Medical Oncology and Hematology University Hospital Zurich Zürich Switzerland.ORCID https://orcid.org/0000-0003-0415-259X
Ivan G CostaInstitute for Computational Genomics, Faculty of Medicine RWTH Aachen University Aachen Germany.
Rebekka K SchneiderDepartment of Developmental Biology Erasmus Medical Center Rotterdam The Netherlands.ORCID https://orcid.org/0000-0002-0749-1565

Funding

Tissue BankP01CA108671 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Ross L Levine · 2006 to 2026
$82.0M
NCI NIH HHS P01 CA108671
6 · The paper itself

Abstract

Bone marrow fibrosis is the most extensive matrix remodeling of the microenvironment and can include de novo formation of bone (osteosclerosis). Spatiotemporal information on the contribution of distinct bone marrow niche populations to this process is incomplete. We demonstrate that fibrosis-inducing hematopoietic cells cause profibrotic reprogramming of perivascular CXCL12-abundant reticular (CAR) progenitor cells, resulting in loss of their hematopoiesis-support and upregulation of osteogenic and pro-apoptotic programs. In turn, peritrabecular osteolineage cells (OLCs) are activated in an injury-specific, Wnt-dependent manner, comparable to skeletal repair. OLCs fuel bone marrow fibrosis through their expansion and skewed differentiation, resulting in osteosclerosis and expansion of Ly6a

Identifiers

PMID41726391
PMCPMC12921528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.